Type 2 diabetes occurs when the pancreas doesn't produce enough insulin to control blood sugar levels, or the insulin ...

Researchers have found in a new study that patients receiving a combination of metformin and SGLT2 inhibitors experienced a ...

Attorney for Southern California-based horseman said contamination from the widely prescribed human drugs led to the apparent ...

Multiple grade 1-winning trainer Mark Glatt is prepared to fight the results of a positive drug test that was posted March 13 ...

Delirium is a serious condition that causes confusion and disorientation. It can come on suddenly and may be triggered by ...

For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonist use is associated with a reduced risk for developing hematologic cancers compared with insulin and metformin use.

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...

The common diabetes drug metformin works partly by excreting sugar from the bloodstream into the intestines, where gut ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...